$AURA
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Elisabet de los Pinos
CEO
106
Employees
$6.55
Current Price
$333.39M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 5 | $528,829.33 | 104,567 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 7 | $618,783.07 | 123,076 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Kilroy Conor Chief Legal Officer and Secretary. | Sale | 12,079 | $5.05 | $60,998.95 | View Details |
| Feb 17, 2026 | Plavsic Mark Chief Technology Officer | Sale | 15,890 | $5.05 | $80,244.50 | View Details |
| Feb 17, 2026 | Hopkins Janet Jill Chief Medical Officer | Sale | 20,401 | $5.06 | $103,229.06 | View Details |
| Feb 17, 2026 | Elazzouzi Amy Senior Vice President, Finance | Sale | 8,549 | $5.06 | $43,257.94 | View Details |
| Feb 17, 2026 | de los Pinos Elisabet Director | Sale | 47,648 | $5.06 | $241,098.88 | View Details |
| Jan 20, 2026 | Elazzouzi Amy Senior Vice President, Finance | Sale | 1,581 | $4.86 | $7,683.66 | View Details |
| Jan 20, 2026 | de los Pinos Elisabet Director | Sale | 16,928 | $4.86 | $82,270.08 | View Details |
10 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.43
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.43
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.